Correlation Between Scpharmaceuticals and Caribou Biosciences
Can any of the company-specific risk be diversified away by investing in both Scpharmaceuticals and Caribou Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Scpharmaceuticals and Caribou Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Scpharmaceuticals and Caribou Biosciences, you can compare the effects of market volatilities on Scpharmaceuticals and Caribou Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Scpharmaceuticals with a short position of Caribou Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Scpharmaceuticals and Caribou Biosciences.
Diversification Opportunities for Scpharmaceuticals and Caribou Biosciences
-0.09 | Correlation Coefficient |
Good diversification
The 3 months correlation between Scpharmaceuticals and Caribou is -0.09. Overlapping area represents the amount of risk that can be diversified away by holding Scpharmaceuticals and Caribou Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Caribou Biosciences and Scpharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Scpharmaceuticals are associated (or correlated) with Caribou Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Caribou Biosciences has no effect on the direction of Scpharmaceuticals i.e., Scpharmaceuticals and Caribou Biosciences go up and down completely randomly.
Pair Corralation between Scpharmaceuticals and Caribou Biosciences
Given the investment horizon of 90 days Scpharmaceuticals is expected to under-perform the Caribou Biosciences. But the stock apears to be less risky and, when comparing its historical volatility, Scpharmaceuticals is 1.33 times less risky than Caribou Biosciences. The stock trades about -0.11 of its potential returns per unit of risk. The Caribou Biosciences is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest 196.00 in Caribou Biosciences on September 1, 2024 and sell it today you would earn a total of 23.00 from holding Caribou Biosciences or generate 11.73% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Scpharmaceuticals vs. Caribou Biosciences
Performance |
| Timeline |
| Scpharmaceuticals |
| Caribou Biosciences |
Scpharmaceuticals and Caribou Biosciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Scpharmaceuticals and Caribou Biosciences
The main advantage of trading using opposite Scpharmaceuticals and Caribou Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Scpharmaceuticals position performs unexpectedly, Caribou Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Caribou Biosciences will offset losses from the drop in Caribou Biosciences' long position.| Scpharmaceuticals vs. Milestone Pharmaceuticals | Scpharmaceuticals vs. Oncolytics Biotech | Scpharmaceuticals vs. Seres Therapeutics | Scpharmaceuticals vs. DiaMedica Therapeutics |
| Caribou Biosciences vs. Intellia Therapeutics | Caribou Biosciences vs. Editas Medicine | Caribou Biosciences vs. Crispr Therapeutics AG | Caribou Biosciences vs. Verve Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Complementary Tools
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |